These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17461196)

  • 1. [PROGRESS trial].
    Yoshimura Y; Shimada K
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():501-5. PubMed ID: 17461196
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebrovascular disease: Impact of INDANA meta-analysis and PROGRESS trial].
    Matsumoto M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():605-11. PubMed ID: 15179938
    [No Abstract]   [Full Text] [Related]  

  • 3. [PROGRESS].
    Hasegawa Y
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():396-401. PubMed ID: 16983776
    [No Abstract]   [Full Text] [Related]  

  • 4. Blood pressure and stroke; the PROGRESS trial.
    He FJ; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):153-5. PubMed ID: 11881116
    [No Abstract]   [Full Text] [Related]  

  • 5. Blood pressure lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and white matter hyperintensities: should this progress matter to patients?
    Schiffrin EL
    Circulation; 2005 Sep; 112(11):1525-6. PubMed ID: 16157782
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
    Scheen AJ
    Rev Med Liege; 2001 Nov; 56(11):792-5. PubMed ID: 11789395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
    Haghfelt T; Haghfelt A
    Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination BP therapy cuts second stroke risk in half.
    Geriatrics; 2001 Aug; 56(8):14, 16. PubMed ID: 11505852
    [No Abstract]   [Full Text] [Related]  

  • 10. Perindopril monotherapy and PROGRESS in Europe.
    Wennberg R; Zimmermann C
    BMJ; 2005 Jul; 331(7510):235-6. PubMed ID: 16037473
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention for stroke and transient ischaemic attacks.
    Muir KW
    BMJ; 2004 Feb; 328(7435):297-8. PubMed ID: 14764462
    [No Abstract]   [Full Text] [Related]  

  • 13. The PROGRESS trial: questions about the effectiveness of angiotensin converting enzyme inhibitors. Perindopril pROtection aGainst REcurrent Stroke Study.
    Psaty BM; Weiss NS; Furberg CD
    Am J Hypertens; 2002 May; 15(5):472-4. PubMed ID: 12022252
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibition in stable coronary artery disease.
    Hackam DG
    CMAJ; 2003 Oct; 169(9):939. PubMed ID: 14581315
    [No Abstract]   [Full Text] [Related]  

  • 15. PROGRESS - Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. Progress Management Committee.
    J Hypertens; 1999 Nov; 17(11):1647-55. PubMed ID: 10608480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial remodelling: an independent pathophysiological component of atherosclerotic disease progression and regression. Insights from serial pharmacological intervention trials.
    Schoenhagen P; Sipahi I
    Eur Heart J; 2007 Oct; 28(19):2299-300. PubMed ID: 17766283
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EUROPA: clinical benefits, clinical promise.
    Cardiovasc J S Afr; 2004; 15(3):147. PubMed ID: 15356915
    [No Abstract]   [Full Text] [Related]  

  • 19. PROGRESS (Perindopril Protection Against Recurrent Stroke Study): regional characteristics of the study population at baseline. PROGRESS Management Committee.
    Chalmers J; Neal B; MacMahon S;
    J Hypertens Suppl; 2000 May; 18(1):S13-9. PubMed ID: 10939785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Control of arterial hypertension in stroke prevention].
    Britov AN; Bystrova MM; Orlov AA
    Klin Med (Mosk); 2002; 80(6):53-7. PubMed ID: 12138805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.